ARTEMIS THERAPEUTICS, INC. (OTCMKTS:INKSD) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of CertainOfficers; Compensatory Arrangements of Certain Officers.
On December 31, 2018, Mr. Gadi Peleg voluntarily resigned from his position as a member of the Board of Directors of Artemis Therapeutics, Inc. (the “Company”). Mr. Peleg did not resign as a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
About ARTEMIS THERAPEUTICS, INC. (OTCMKTS:INKSD)
Artemis Therapeutics, Inc., formerly New York Global Innovations Inc., seeks to offer alternatives to allergy medications. The Company provides various dietary and lifestyle guidelines, and also offers Lucidia and approximately six Chinese herb support formulas for purchase or prescription filling. The Company offers Artemis Allergy Relief Program, which is an educational resource center for health care practitioners, patients, and anyone suffering from seasonal, environmental or pet allergies. The program is a natural approach to allergy treatment or can be used alongside various therapies. The program provides various tools and natural medicinals to cultivate health and mitigate allergy symptoms. Artemis Allergy Treatment Program is intended for people suffering from seasonal allergies or yearlong allergies to pollens, animals, mold, dust, grasses, trees and hay fever.
